New Nobel Biocare president is the customer and dental expert in the company’s history to take the reins as its highest-ranking executive
As of January 1, Hans Geiselhöringer has taken over as president of Nobel Biocare. The appointment was made to strengthen the organization around its strategic goals.
Since 2011 Hans Geiselhöringer has served as executive vice president of Global Research, Products, and Development, shaping a highly competitive product and innovation pipeline. Prior to that he was executive vice president Global Marketing and Products from 2010 to 2011 and head of NobelProcera and Guided Surgery from 2009 to 2010. Hans joined Nobel Biocare as head of NobelProcera in 2008 and was appointed a member of the executive committee in 2009.
From 2004 to 2009, Hans acted as a global speaker for Nobel Biocare; with this appointment, he becomes the first Nobel Biocare customer and dental expert in the company’s history to take the reins as its highest-ranking executive.
In 1998, he founded DentalX GmbH, a leading dental laboratory chain specializing in implantology, anaplastology, functional and esthetic reconstructions, and imaging technologies. Hans is a trained dental technician and possesses great technical knowledge of the implant and CAD/CAM industries, as well as deep customer understanding and insights, enabling continuity of innovation at Nobel Biocare.
As an expert on dental technologies and materials, he has published/copublished various clinical and research articles. He is also a member of numerous international dental associations and a recognized lecturer at dental conventions throughout the world.
He said, “Our focus on the patient remains steadfast and constant. Everything we do will continue to be patient centered, clinically relevant and evidence based. To strengthen our leadership in implant-based dentistry we strongly focus on providing integrated digital solutions to improve the customer experience and increase productivity on all levels while ensuring a high level of clinical success and predictability. With our counterparts at KaVo Kerr Group, we have all the pieces in place today and we are grouping our highly skilled global teams together to form the industry’s new digital dentistry powerhouse. In summary, we at Nobel Biocare will continue our strong commitment to innovation, providing an ongoing pipeline of superior solutions that helps more customers treat more patients better.”
Editor's note: To keep up with more industry news like this, subscribe to the Apex360 e-newsletter here.
Source: Nobel Biocare press release 18 January 2016
